Pérez-Simón J A, Caballero M D, Corral M, Nieto M J, Orfao A, Vazquez L, Amigo M L, Berges C, González M, Del Cañizo C, San Miguel J F
Department of Hematology, University Hospital, Salamanca, Spain.
Transfusion. 1998 Apr;38(4):385-91. doi: 10.1046/j.1537-2995.1998.38498257378.x.
The number of peripheral blood (PB) CD34+ cells has been widely used to monitor the timing of leukapheresis for autologous transplantation. However, no cutoff value for CD34+ cells in PB has been defined as a guideline for the identification of patients in whom the harvest would be effective and those in whom there was a high probability of failure.
The present study investigated the best threshold of CD34+ cells in PB for successful harvesting and engraftment, using 263 PB samples with their corresponding leukapheresis components. In addition, that measure has been compared to other commonly used criteria such as the white cell count, the number of mononuclear cells, and the number of colony-forming units-granulocyte macrophage in PB.
Time to engraftment of both granulocytes and platelets was significantly influenced by the number of CD34+ cells transfused, but all patients receiving > or = 0.75 x 10(6) CD34+ cells per kg achieved engraftment within a reasonable number of days (> 0.5 x 10(9)/L granulocytes by Day 11 and > 20 x 10(9)/L platelets by Day 13). A clear correlation between the number of CD34+ cells per microL in PB and of CD34+ cells per kg collected was found at each apheresis (r = 0.9, p < 0.0001). Moreover, the number of CD34+ cells per microL measured in PB the day the first leukapheresis was initiated displayed an excellent correlation with the total amount of CD34+ cells per kg finally collected (r = 0.81, p < 0.0001). On the basis of the regression curve obtained and the clinical engraftment results, it was found that the presence of > 5 CD34+ cells per microL in PB ensured a good yield from the harvest in 95 percent of patients and would avoid an unsuccessful harvest in 81 percent of cases.
A dose of only 0.75 x 10(6) CD34+ cells per kg guarantees hematopoietic recovery within a reasonable number of days. To initiate a leukapheresis from which enough progenitor cells may confidently be obtained, a minimum of 5 CD34+ cells per microL in PB is required.
外周血(PB)中CD34+细胞数量已被广泛用于监测自体移植白细胞单采的时机。然而,PB中CD34+细胞的临界值尚未被定义为识别采集有效患者和高失败概率患者的指南。
本研究使用263份PB样本及其相应的白细胞单采成分,调查PB中CD34+细胞用于成功采集和植入的最佳阈值。此外,还将该指标与其他常用标准进行了比较,如PB中的白细胞计数、单核细胞数量和粒系巨噬系集落形成单位数量。
粒细胞和血小板的植入时间受输注的CD34+细胞数量显著影响,但所有接受≥0.75×10⁶个/kg CD34+细胞的患者在合理天数内实现了植入(第11天粒细胞>0.5×10⁹/L,第13天血小板>20×10⁹/L)。每次单采时,PB中每微升CD34+细胞数量与每千克采集的CD34+细胞数量之间存在明显相关性(r = 0.9,p < 0.0001)。此外,首次白细胞单采当天PB中测得的每微升CD34+细胞数量与最终每千克采集的CD34+细胞总量显示出极好的相关性(r = 0.81,p < 0.0001)。根据获得的回归曲线和临床植入结果,发现PB中每微升>5个CD34+细胞可确保95%的患者采集产量良好,并可避免81%的病例采集失败。
每千克仅0.75×10⁶个CD34+细胞的剂量可确保在合理天数内实现造血恢复。为启动能可靠获得足够祖细胞的白细胞单采,PB中每微升至少需要5个CD34+细胞。